Effect of Hybrid Robot-assisted Training Using End-effector and Exoskeleton Devices in Distal Upper Extremity After Stroke:Motor Control, Motor and Daily Function, Quality of Life
Launched by CHANG GUNG MEMORIAL HOSPITAL · Feb 4, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of different types of robot-assisted training on stroke patients. The goal is to see how these training methods can help improve patients' movements, daily activities, and overall quality of life. The trial compares a hybrid approach that uses both end-effector and exoskeleton devices, as well as traditional training methods, to find out which is most effective for recovery after a stroke.
To participate, individuals need to have had a stroke for more than three months and have some movement difficulties on one side of their body. They should be able to understand instructions and provide consent to join the study. Participants can expect to engage in various training sessions that involve advanced robotic devices designed to assist with their rehabilitation. This trial is currently looking for volunteers, and it aims to help improve rehabilitation techniques for stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke more than 3 months.
- • Modified Ashworth Scale proximal part ≤ 3, Modified Ashworth Scale distal part ≤ 2, and no serious muscle spasms.
- • The myoelectric signal can be detected to activate the instrument
- • Unilateral paresis (FMA score\<60)
- • No serious cognitive impairment (i.e., Mini Mental State Exam score \> 24)
- • Can provide informed consent
- Exclusion Criteria:
- • Other neurological disease
- • Complete sense of body defect
- • Inability to understand instructions
- • current participation in any other research
- • Botulinum Toxin injection within 3 months
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taoyuan, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials